The company plans to bring to market in the coming years a series of microarray-based tests for autoimmune diseases and allergies, among other tests.

The company hopes to complete proof of principle for a companion diagnostic to identify patients with PCa who are likely to need aggressive treatment.

NEW YORK — Sysmex America said on Wednesday that it has received licensing from Health Canada for its CN-3000 and CN-6000 automated blood coagulation analyzers. The CN-3000 and CN-6000 are designed ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

The approval enables Trinity to transition upstream production from in-house operations to an outsourced model.

The bank's analysts favor diagnostics over life science tools as it doesn't face some of the headwinds more prevalent among tool vendors.

The test is designed to stratify patients diagnosed with pancreatic cystic lesions based on their risk of developing pancreatic cancer.

The firm's Clinical Viewer is cleared for use with the Hamamatsu NanoZoomer S360MD Slide scanner, NDPI image formats, and the Barco NV MDPC-8127 display.

With the registration, the analyzer can be used for clinical testing in South Korea, expanding Quanterix's reach in that country's in vitro diagnostic and clinical laboratory markets.

Last week, readers were most interested in a story about an MOU between EDX Medical Group and Spire Healthcare centered on diagnostic products and testing services.

Plasma Services Group provides sera and other samples for materials of control reagents and calibrators for a variety of diseases.

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to ...